Hyperfine (HYPR) Preferred Stock Liabilities (2020 - 2022)
Hyperfine (HYPR) posted Preferred Stock Liabilities of $333.2 million for Q4 2022, up 3.3% on a QoQ basis from $322.5 million in Q4 2021, and up 3.3% year-over-year from $322.5 million in Q4 2021.
Hyperfine (HYPR) Preferred Stock Liabilities (2020 - 2022) Analysis & Trends
Hyperfine's Preferred Stock Liabilities history runs 3 years deep, the most recent figure standing at $333.2 million for Q4 2022.
- Quarterly Preferred Stock Liabilities rose 3.3% year-over-year to $333.2 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $333.2 million (up 3.3% YoY) and the FY2022 annual result came in at $333.2 million, up 3.3% from the prior year.
- Preferred Stock Liabilities was $333.2 million for Q4 2022 at Hyperfine, up from $322.5 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $333.2 million in Q4 2022 and bottomed at $10.9 million in Q1 2021.
- A 3-year average of $169.0 million and a median of $167.6 million in 2020 frame the typical range for Preferred Stock Liabilities.
- Annual changes were most pronounced in 2021 — Preferred Stock Liabilities jumped 151.42% — and 2022, when it grew 3.3%.
- Hyperfine's Preferred Stock Liabilities stood at $128.3 million in 2020, then jumped by 151.42% to $322.5 million in 2021, then advanced by 3.3% to $333.2 million in 2022.
- Business Quant data shows HYPR's Preferred Stock Liabilities at $333.2 million in Q4 2022, $322.5 million in Q4 2021, and $207.0 million in Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 333.20 Mn |
| Dec 31, 2021 | 322.54 Mn |
| Sep 30, 2021 | 207.00 Mn |
| Jun 30, 2021 | 12.35 Mn |
| Mar 31, 2021 | 10.92 Mn |
| Dec 31, 2020 | 128.29 Mn |